Dr. Edward Champoux, MD

Dr. Champoux practices at Smith Allergy and Asthma of Central New York in Corning, New York.

Dr. Champoux's NPI, 1851387724, was assigned on September 26, 2005. Dr. Champoux graduated from Albany Medical College of Union University in 1996. Dr. Champoux holds New York license 318518.

Dr. Champoux's primary practice is Smith Allergy and Asthma of Central New York, at 88 E Tioga Ave, Corning, NY 14830 in Steuben County. The practice phone is (607) 684-6115.

Dr. Champoux's primary practice is Smith Allergy and Asthma of Central New York in Corning, New York. Dr. Champoux is also affiliated with UHS Binghamton General Hospital. The medical group on file is Smith Allergy & Asthma Specialists of Central NY. Dmand AI also links Dr. Champoux to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Champoux practices, 4 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Champoux's primary specialty in the NPI Registry, under taxonomy code 207RA0201X. Dmand AI has Dr. Champoux's licenses on file in 2 states: New York and Indiana.

CMS data shows 2,592 Medicare services from Dr. Champoux across 10 procedure codes in 2024, for 323 Medicare patients. Medicare paid $31,585 for them. Every service was in an office.

CMS counts 323 Medicare patients who saw Dr. Champoux in 2024. The largest group is 65 to 74, with 155 patients. 63% of them have high blood pressure, and 63% have high cholesterol. 19% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Champoux's median patient age at 35, with 64% women.

In 2024, Dr. Champoux wrote 377 Medicare Part D claims for 145 patients. 75% of them were for generic drugs. CMS names the drug for 268 of them, across 8 drugs with 11 or more claims each, at $33,720 in total drug cost. In 2023, CMS named 129 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Champoux for performance year 2024, reported through an alternative payment model (APM). Dr. Champoux accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Champoux in 2019. Dr. Champoux's most frequent co-authors are Christopher Albert Coop, MD, Michael P. Carroll, MD and Howard Crisp, MD.

CMS Open Payments shows 330 general payments to Dr. Champoux from 30 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,279. It also lists 14 research payments totaling $2,079 in 2024, naming 1 clinical trial.

Dr. Champoux graduated from Albany Medical College of Union University in 1996.